MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 130 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $32,000 | -65.6% | 25,940 | -13.8% | 0.01% | -67.9% |
| Q1 2017 | $93,000 | -31.1% | 30,090 | -9.3% | 0.03% | -34.9% |
| Q4 2016 | $135,000 | -56.3% | 33,190 | -31.7% | 0.04% | -55.7% |
| Q3 2016 | $309,000 | +27.7% | 48,601 | +8.3% | 0.10% | +24.4% |
| Q2 2016 | $242,000 | -35.5% | 44,861 | 0.0% | 0.08% | -38.6% |
| Q1 2016 | $375,000 | +124.6% | 44,861 | +112.7% | 0.13% | +115.3% |
| Q4 2015 | $167,000 | +10.6% | 21,090 | +19.2% | 0.06% | -3.3% |
| Q3 2015 | $151,000 | -28.4% | 17,700 | +3.5% | 0.06% | -17.6% |
| Q2 2015 | $211,000 | -9.4% | 17,100 | -12.8% | 0.07% | -17.8% |
| Q1 2015 | $233,000 | -0.4% | 19,600 | -5.3% | 0.09% | -3.2% |
| Q4 2014 | $234,000 | – | 20,700 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 2,211,880 | $17,474,000 | 4.63% |
| Parametrica Management Ltd | 21,228 | $168,000 | 1.11% |
| GARRISON BRADFORD & ASSOCIATES INC | 82,700 | $653,000 | 0.73% |
| Virtus ETF Advisers LLC | 33,570 | $265,000 | 0.73% |
| Opus Point Partners Management, LLC | 122,500 | $968,000 | 0.64% |
| NEXTHERA CAPITAL LP | 36,000 | $284,000 | 0.40% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 7,255,815 | $57,321,000 | 0.39% |
| Cannell & Co. | 1,051,178 | $7,751,000 | 0.25% |
| Tekla Capital Management LLC | 853,787 | $6,745,000 | 0.24% |
| STONERIDGE INVESTMENT PARTNERS LLC | 208,282 | $1,645,000 | 0.22% |